ArticleEuropean journal of nuclear medicine and molecular imaging2021
In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study.
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of PET/MR in Patients Selected for Ablation Therapy
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Sarcolemmal and mitochondrial membrane potentials measured ex vivo and in vivo in the heart by pharmacokinetic modelling of [The Journal of physiology · 2026Article
- In vivo 3D myocardial membrane potential mapping in humans using PET/MRI.EJNMMI research · 2025Article
- Molecular imaging: The bridge from human phenome to personalized precision medicine.European journal of nuclear medicine and molecular imaging · 2025Article
- Aging imaging: the future demand of health management.European journal of nuclear medicine and molecular imaging · 2023Article
- Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease.Endocrine reviews · 2023Review
- Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium.Pharmaceutics · 2023Review
- Biomarkers of aging.Science China. Life sciences · 2023Review
- PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study.Scientific reports · 2022Article
- Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.Frontiers in cardiovascular medicine · 2022Review
- Cardiac hybrid imaging: novel tracers for novel targets.Journal of geriatric cardiology : JGC · 2021Article
- Mitochondrial energetics with transmembrane electrostatically localized protons: do we have a thermotrophic feature?Scientific reports · 2021Article
- Energy Renewal: Isothermal Utilization of Environmental Heat Energy with Asymmetric Structures.Entropy (Basel, Switzerland) · 2021Article
- Quantification of Myocardial Mitochondrial Membrane Potential Using PET.Current cardiology reports · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
Abstract
purposeAlteration in mitochondrial membrane potential (ΔΨ
methodsThirteen healthy subjects were imaged using [
resultsIn 13 healthy subjects, average tissue membrane potential (ΔΨ
conclusionIn vivo quantification of the mitochondrial function has the potential to provide new diagnostic and prognostic information for several cardiac diseases as well as allowing therapy monitoring. This feasibility study lays the foundation for further investigations to assess these potential roles. Clinical trial identifier: NCT03265431.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.